Clinical effects of simvastatin in chronic hepatitis C patients receiving sofosbuvir/daclatasvir combination. A randomized, placebo-controlled, double-blinded study.

Follow-up values Analysis and comparison of the serial laboratory measurements (baseline, 1st, 2nd, 3rd and 6th months after therapy) of patients in both groups revealed that the average platelets, total leucocyte count (TLC) and neutrophils were increased during serial measurements with a highly significant difference ( p < 0.001 respectively).

also in 132,142 other papers